All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 9 out of 29 Insights
-
Active Filters
-
Fewer Hospital Readmissions? Challenging Pay-for-Performance
J. Michael McWilliams, MD, PhD, the Warren Alpert Foundation Professor of Health Care Policy at the Blavatnik Institute at Harvard Medical School and an internist at Brigham and Women’s Hospital, discusses hospital readmissions and pay-for-performance measures.
-
Advancing Genomic Editing and Organoids
Genomic scientist George Church, PhD, professor of Genetics at Harvard Medical School, discusses approaches to genome editing and applications for organoids in drug discovery and development.
-
Tracing the Arc of Precision Therapies for Kidney Disease
Physician-scientist Anna Greka, MD, PhD, associate professor at Harvard Medical School, founding director of Kidney NExT at Brigham and Women’s Hospital and director of the Broad Institute Kidney Disease Initiative, discusses groundbreaking work on a rare kidney disease, prospects for new therapeutics and collaborating on drug development.
-
Removing the Sage from the Stage: Blending Case- and Problem- Based Learning in Graduate Biomedical Research Education
In this Harvard Macy Institute blog post, the use of case and problem-based learning in graduate biomedical research training is discussed.
-
Designing Better Surveys for Education and Research
In this Harvard Macy Institute blog post, Anthony R. Artino discusses six principles that guide the design and development of high-quality surveys in health professions education.
-
Cancer Care Delivery: Moving at the Pace of Innovation
Mara Bloom, JD, MS, the executive director of Mass General Cancer Center, discusses the future of cancer care delivery, grappling with cost, and access to clinical trials.
-
Patient Perspective: Linnea Olson, Cancer Activist
Linnea Olson, a lung cancer activist and blogger, discusses terms of respect, patient-centered drug development, and online patient communities.
-
Cancer Immunotherapy: Chasing a Durable Cure
Justin F. Gainor, MD, director of targeted immunotherapy at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, answers three questions about cancer immunotherapy.
-
Assessing Clinical Reasoning: Identifying the GAP
MedEdPearls November 2018: What strategies might you use to address gaps in clinical reasoning?